Vanguard Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$110M Buy
8,942,647
+716,542
+9% +$8.98M ﹤0.01% 1469
2026
Q2
$121M Buy
8,226,105
+700,176
+9% +$4.83M ﹤0.01% 1449
2026
Q1
$31.8M Buy
+7,525,929
New +$33.7M ﹤0.01% 2092

Other funds holding SLS

Vanguard Capital Management's SLS Position: Q3 2026 in Review

Vanguard Capital Management increased its SELLAS Life Sciences (SLS) stake by 8.7% in Q3 2026, buying an estimated $8.98M and bringing the position to 8,942,647 shares worth $110M. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Vanguard Capital Management first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $121M in Q2 2026. 217 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Vanguard Capital Management held 8,942,647 shares of SELLAS Life Sciences worth $110M as of Q3 2026.
  • Vanguard Capital Management bought 716,542 SELLAS Life Sciences shares in Q3 2026, an estimated $8.98M.
  • SELLAS Life Sciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1469 holding.
  • Vanguard Capital Management first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's SELLAS Life Sciences position peaked at $121M in Q2 2026.
  • 217 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.